MARGINAL ZONE LYMPHOMA
Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to replace chemo for rare lymphoma
Disease control TerminatedThis study tested a chemotherapy-free combination of pembrolizumab and rituximab in 22 people with marginal zone lymphoma (a slow-growing blood cancer). The goal was to see if this combo could control the disease as well as standard chemo but with fewer side effects. The trial wa…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Ulm • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Immune drug shows promise in untreated lymphoma study
Disease control TerminatedThis study tested the drug pembrolizumab in 9 people with untreated B-cell non-Hodgkin lymphoma. The goal was to see if it could shrink tumors by helping the immune system attack cancer cells. The trial was stopped early, so results are limited.
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Promising lymphoma combo study halted early
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New imaging agent aims to improve lymphoma staging
Diagnosis TerminatedThis study tested a new imaging agent called [68Ga]Ga-PentixaFor to see if it could find lymphoma tumors better than the standard PET scan. The trial planned to include adults with marginal zone lymphoma who had not yet been treated. However, the study was stopped early after onl…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Jun 15, 2026 19:05 UTC